Light Mode
$14.87 ↓ -0.95 (-6.01%) Trading Down from the previous close of $15.82, and at the day’s high of $14.87
+1.52 (+11.39%) / 6M
Momentum, market sentiment, and recent alerts
ALFRY reads n/a: the 12-month move is +14.5%.
No alerts for ALFRY in the last day.
Earnings, valuation, and balance sheet
Company profile and competitor comparison
Alfresa Holdings Corp. engages in the management of its subsidiaries that deal with wholesaling, manufacturing, import, and export of pharmaceutical products, diagnostic reagents, and medical devices. It operates through the following segments: Ethical Pharmaceuticals Wholesaling, Self-Medication Products Wholesaling, Manufacturing, and Medical-related. The Ethical Pharmaceuticals Wholesaling segment provides wholesale prescription drugs, medical diagnostic reagents, medical devices, equipment, and materials to hospitals, clinics, dispensing pharmacies, and other institutions. The Self-Medication Products Wholesaling segment sells over-the-counter drugs, health food, and supplements. The Manufacturing segment manufactures and markets pharmaceutical ingredients, pharmaceuticals, diagnostic reagents, and medical devices. The Medical-related segment offers medical services through its dispensing pharmacies. The company was founded on September 29, 2003 and is headquartered in Tokyo, Japan.
Real-time scanning and AI-generated signals across the entire market.
Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.